CIK 0001661181 · Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-15 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −6,667 | $3.73 | $25K | 182,498 |
| 2026-02-15 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −5,549 | $3.73 | $21K | 176,949 |
| 2026-02-15 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −5,442 | $3.73 | $20K | 171,507 |
| 2026-02-15 | Freedman Lori Chief Admin. and Legal Officer | Shares withheld for taxes | −4,043 | $3.73 | $15K | 842,416 |
| 2026-02-15 | Freedman Lori Chief Admin. and Legal Officer | Shares withheld for taxes | −24,428 | $3.73 | $91K | 817,988 |
| 2026-02-15 | Freedman Lori Chief Admin. and Legal Officer | Shares withheld for taxes | −12,761 | $3.73 | $48K | 805,227 |
| 2026-02-15 | Freedman Lori Chief Admin. and Legal Officer | Shares withheld for taxes | −13,510 | $3.73 | $50K | 791,717 |
| 2026-02-15 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −24,340 | $3.73 | $91K | 3,490,983 |
| 2026-02-15 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −78,646 | $3.73 | $293K | 3,412,337 |
| 2026-02-15 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −82,815 | $3.73 | $309K | 3,329,522 |
| 2026-02-15 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −85,605 | $3.73 | $319K | 3,243,917 |
| 2026-02-15 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −3,346 | $3.73 | $12K | 669,031 |
| 2026-02-15 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −18,910 | $3.73 | $71K | 650,121 |
| 2026-02-15 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −10,559 | $3.73 | $39K | 639,562 |
| 2026-02-15 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −11,144 | $3.73 | $42K | 628,418 |
| 2026-02-15 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −1,389 | $3.73 | $5K | 195,291 |
| 2026-02-15 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −9,607 | $3.73 | $36K | 185,684 |
| 2026-02-15 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −4,100 | $3.73 | $15K | 181,584 |
| 2026-02-15 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −3,523 | $3.73 | $13K | 178,061 |
| 2025-12-16 | NUSSDORF GLENN H Director | Sale | −200,000 | $5.14 | $1.0M | 2,565,591 |
Page 4 of 12 · 228 trades